Effects of an Exercise Program for Children With Asthma

February 25, 2020 updated by: Margarita Perez, Universidad Europea de Madrid

Effects of an Intra-hospital Exercise Program for Children With Asthma and Respiratory Symptoms

exercise program in the pulmonary function and cardiorespiratory fitness in children with asthma and respiratory symptoms

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study aims to analyze the effects of an exercise program in the pulmonary function, cardiorespiratory fitness, diet quality index, physical activity, body composition, muscle function, agility, and psychological health in a group of children with asthma and respiratory symptoms

Study Type

Interventional

Enrollment (Actual)

53

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Madrid, Spain, 28009
        • Hospital Infantil Universitario Nino Jesus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosed with Asthma following the GEMA 2009 criteria (Spanish Guide for Asthma Management) at least 6 months prior to the study.
  • Complete successfully both Cardiorespiratory and Functional Tests.

Exclusion Criteria:

  • Diagnosed with other chronic respiratory disease or condition
  • Diagnosed with any chronic disease including cardiovascular diseases.
  • Reduced mobility
  • Uncooperative
  • Poor adherence to medication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Children who follow the recommendations of their pneumologist
Experimental: Experimental
A two month intervention program 3 days/week will be carried out. The session will last ~60 minutes, and will consist of a combined training (aerobic training ~30 min, and strength ~30 min of 7 whole body exercises (3 sets x 10 repetitions).The load was gradually increased as the strength of each child improved, i.e., from 40% of five-repetition maximum (5RM) lifting ability at the start of the program to 60% of 5RM at the end of the program. All sessions were individually supervised by trained professionals.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Pulmonary Function (Lung Function)
Time Frame: Baseline, 2 months, and 3 months
Change from baseline to 2 months, and 3 months
Baseline, 2 months, and 3 months
Change in Cardiorespiratory Fitness
Time Frame: Baseline, 2 months, and 3 months
Change from baseline to 2 months, and 3 months using Cardiorespiratory Test
Baseline, 2 months, and 3 months
Change in Muscle Strength
Time Frame: Baseline, 2 months, and 3 months
Change from baseline to 2 months, and 3 months using one repetition maximum test
Baseline, 2 months, and 3 months
Change in Quality of life and anxiety status
Time Frame: Baseline, 2 months, and 3 months
Change from baseline to 2 months, and 3 months using the Paediatric Asthma Quality of Life Questionnaire (PAQLQ) (Guyatt GH, 1997)
Baseline, 2 months, and 3 months
Change in anxiety
Time Frame: Baseline, 2 months, and 3 months
Change from baseline to 2 months, and 3 months using STAIC (State-Trait Anxiety Inventory for Children)
Baseline, 2 months, and 3 months
Change in Body Mass Index (BMI)
Time Frame: Baseline, 2 months, and 3 months
Change from baseline to 2 months, and 3 months using height and weight.
Baseline, 2 months, and 3 months
Change in Waist-to-Height index
Time Frame: Baseline, 2 months, and 3 months
Change from baseline to 2 months, and 3 months using height and waist.
Baseline, 2 months, and 3 months
Change in anthropometric outcomes
Time Frame: Baseline, 2 months, and 3 months
Change from baseline to 2 months, and 3 months using skinfolds, and circumferences.
Baseline, 2 months, and 3 months
Change in Body Composition
Time Frame: Baseline, 2 months, and 3 months
Change from baseline to 2 months, and 3 months using Bioimpedance.
Baseline, 2 months, and 3 months
Changes in Physical Activity using questionnaires
Time Frame: Baseline, 2 months, and 3 months
Change from baseline to 2 months, and 3 months using Physical Activity Questionnaire for Children (PAQ-C) and Adolescents (PAQ-A)
Baseline, 2 months, and 3 months
Change in Agility walking
Time Frame: Baseline, 2 months, and 3 months
Change from baseline to 2 months, and 3 months using Test of Up and Go
Baseline, 2 months, and 3 months
Change in Agility stairs.
Time Frame: Baseline, 2 months, and 3 months
Change from baseline to 2 months, and 3 months using Test of Up and Down Stairs (TUDS)
Baseline, 2 months, and 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Margarita Perez Ruiz, MD, PhD, Universidad Europea de Madrid

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2016

Primary Completion (Actual)

May 1, 2018

Study Completion (Actual)

October 1, 2018

Study Registration Dates

First Submitted

February 2, 2016

First Submitted That Met QC Criteria

February 22, 2016

First Posted (Estimate)

February 26, 2016

Study Record Updates

Last Update Posted (Actual)

February 28, 2020

Last Update Submitted That Met QC Criteria

February 25, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asthma

Clinical Trials on Exercise program

Subscribe